Acridone compounds
US8987296B2 · kind B2 · utility
1Cited by
16References
27Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 29, 2013 |
| Grant date | Mar 24, 2015 |
| Priority date | — |
| Expiry date | Oct 29, 2033 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A class of acridone compounds has been discovered that exhibits chemosensitizing and antiparasitic activity. Described herein are pharmaceutical compositions and methods for their use to treat parasitic infections, such as malaria and toxoplasmosis, and to sensitize resistant cells, such as multidrug resistant cells to other therapeutic agents. The pharmaceutical compositions and methods may also be used to treat and/or prevent psychotic diseases such as schizophrenia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.